Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 47

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 47
---
 (as adjusted for stock splits, stock dividends, right issuances, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing six months after the Business Combination,or or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of our stockholders having the right to exchange their shares of common stock for cash, securities or other property. Reasonableness of Merger Consideration. Following a review of the financial data provided to FutureTech, including the historical financial statements of Longevity and the Targets and certain unaudited prospective financial information discussed in the section entitled “Shareholder Proposal No. 1 — The Business Combination Proposal — Projected Financial Information” and FutureTech’s due diligence review and financial and valuation analyses of Longevity, the FutureTech Board considered the transaction consideration to be issued to Longevity’s equityholders and determined that the consideration was reasonable in light of such data and financial information. Of note, the Merger Consideration represents a discount to the valuation range of (i) the equity value of $225.9 million obtained by comparing the equity valuation of twelve comparable public companies in three different healthcare sub-verticals and (ii) the estimated $183.0 million valuation implied by a discounted cash flow analysis performed by Newbridge. For more information, see “Proposal No. 1 — The Business Combination Proposal — Opinion of Newbridge;” Fairness Opinion. The FutureTech Board considered the opinion delivered by Newbridge to the effect that, as of the date of the opinion, and subject to and based on the assumptions made, procedures followed, matters considered, limitations of review undertaken and qualifications contained in the opinion, the Merger Consideration is fair to FutureTech and its unaffiliated stockholders from a financial point of view; Other Alternatives.After a review of other business combination opportunities reasonably available to FutureTech, the FutureTech Board believes that the proposed Business Combination represents the best potential business combination for FutureTech and the most attractive opportunity for FutureTech’s shareholders based upon the process utilized to evaluate and assess other potential acquisition targets; and Negotiated Transaction. The terms and conditions of the Merger Agreement and the related agreements and the transactions contemplated thereby, each party’s representations, warranties and covenants, the conditions to each party’s obligation to consummate the Business Combination and the termination provisions, were the product of arms-length negotiations, and, in the view